The incidence of complications, including infectious and major complications, appeared to be higher in the MD-MAFLD group compared to the non-MD-MAFLD group, however, these differences did not reach statistical significance (33.3% vs 22.7%, P = 0.115; 30.0% vs 19.3%, P = 0.099; 12.2% vs 11.4%, P = 0. 859; respectively).
← all excerpts
Metabolic dysfunction-associated fatty liver disease increases the risk of complications after radical resection in patients with hepatocellular carcinoma.
1
0.1150
0.1150